Zobrazeno 1 - 10
of 54
pro vyhledávání: '"H.-J. Heberling"'
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 104:50-58
Direct multi-colour flow cytometric analysis was employed in patients with Graves' disease (n = 10) to determine the immunophenotype in peripheral blood lymphocytes (PBL) at the time of diagnosis without treatment (PBLw) and prior to operation (PBLp)
Autor:
Tina Mühlberg, Werner Joba, H.-J. Heberling, Armin E. Heufelder, Kathrin Herrmann, M. Kirchberger
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 85:2640-2643
Constitutively activating mutations of the human TSH receptor (hTSHR) gene have been implicated as a major cause of hyperfunctioning nonautoimmune thyroid disease. However, significant geographic differences in the prevalence of these mutations have
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(8)
Constitutively activating mutations of the human TSH receptor (hTSHR) gene have been implicated as a major cause of hyperfunctioning nonautoimmune thyroid disease. However, significant geographic differences in the prevalence of these mutations have
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(2)
Recent data have indicated that orbital fibroblasts (OF) can be stimulated to produce marked quantities of interleukin-1 receptor antagonist (IL-1RA), a powerful inhibitor of the proinflammatory activities of interleukin-1 in the orbital tissues in G
Autor:
M. Kirchberger, Christine Spitzweg, Armin E. Heufelder, F Herrmann, T Muhlberg, H.-J. Heberling
Publikováno v:
European journal of endocrinology. 138(6)
OBJECTIVE: To assess whether the A2-type IL-1RA polymorphism is associated with Graves' disease and Graves' ophthalmopathy. Several reports have described a genetic association between the A2 allele of the interleukin-1 receptor antagonist (IL-1RA) g
Publikováno v:
Investigative ophthalmologyvisual science. 38(5)
To analyze the expression and regulation of intracellular and soluble interleukin-1 (IL-1) receptor antagonist (IL-1RA) in orbital fibroblasts and to determine whether a disbalance between IL-1 receptor agonist and antagonist may promote IL-1 mediate
Autor:
C, Wünsch, H J, Heberling
Publikováno v:
Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten. 44(1)
Up to the present time lithium therapy is under discussion in patients with severe, particularly of contrast remedy induced hyperthyroidism. The aim of our presentation was to investigate if the short term combined methimazole-lithium therapy in the
Publikováno v:
Radiobiologia, radiotherapia. 28(5)
Publikováno v:
Der Pathologe. 9(1)
Publikováno v:
Zeitschrift fur arztliche Fortbildung. 75(23)